Skip to main content
. 2021 Oct 4;12:727850. doi: 10.3389/fimmu.2021.727850

Table 3.

Routine immunological evaluation at baseline.

Pt1 Pt2 Pt3 Pt4 Pt5 Pt6 Pt7 Pt8 Pt9 Pt10 Pt11
Hb (mg/dl) 15.1 16.9 15.5 14.3 15.2 12.9 14.1 15.4 15.2 12.2 14.4
PLT (10x3/ml) 123 174 214 245 129 228 259 165 218 253 192
WBC (10x3/ml) 9.07 6.22 7.6 5.39 4.06 9.01 4.76 4.42 5.79 3.73 4.52
Eosinophils (% and 10x3/ml) 1.3/120 2.9/180 2.5/190 0.4/20 4.4/180 7.3/660 1.3/60 2.3/100 5.7/330 1.1/40 3.5/220
Total lymphocytes (10x3/ml) 1.05 2.76 2.6 2.7 1.6 4.8 2.2 1.2 2.3 1.2 1.1
CD3+ (% and cell/µl) 87/913 81/2235 83/2158 64.7/1746 77/1232 86/4128 58/1276 70/840 70/1610 73/876 82.7/909
CD4+ (% and cell/ µl) 46/483 65/1794 36/936 37/999 27/432 38/1824 36.7/807 48/576 37/851 40.6/487 39.7/436
CD8+ (% and cell/ µl) 41/430 15/414 44/1144 24/648 45/720 31.7/1521 17/374 20/240 25/575 17/204 42.1/463
CD19+ (% and cell/µl) 5.5/52 9/248 6.7/174 17/459 12/192 6.3/302 26/572 18/216 17/391 19.8/237 8/88
CD16+56+ (% and cell/µl) 6.5/68 8.8/243 9.9/257 15.6/421 7/112 7.8/374 8.7/191 11/132 9/207 12.2/146 6.1/66
CD3+CD4+CD27+CD45RO- Naïve T cell (%) 26 68.6 52.9 64.2 41.9 79 70.5 66.5 70 27.2 48
CD3+CD4+CD27+CD45RO+ Tcm (%) 49.9 25.4 33.2 25.9 49.1 12.2 22.2 26.8 21.7 68.6 41.1
CD3+CD4+CD27-CD45RO+ Tem (%) 4.52 1.43 1.14 1.98 2.54 3.79 1.13 1.94 2.73 0.31 1.88
CD3+CD4+CD27-CD45RO- Temra (%) 17.2 2.37 8.74 6.08 5.5 3.93 3.11 2.99 3.54 2.73 6.59
CD3+CD4+CD27+CD45RO+CXCR5+ pTfh (%) 28.9 24.9 18.7 24.3 45.5 8.22 23.3 12.8 17 53.9 30.3
CD27-IgD- Double negative B cells (%) 16.5 0.86 2.11 6.61 1.13 3.77 2.58 8.29 8.62 7.48 1.56
CD27+IgD+ Unswitched memory B cells (%) 3.46 0.39 0.56 11.9 3.46 4.99 0.85 9.73 11.8 14 2.23
CD27+IgD- Switched memory B cells (%) 13.8 0.054 0.25 8.11 0.13 5.5 1.26 5.19 5.49 4.16 0.83
CD27-CD21+ Naïve B cells (%) 50.4 96.7 85.1 66.4 83.6 34.6 91.5 63 62.6 37.6 90.5
CD27-CD21- TLM B cells (%) 27.1 1.75 13.5 5.59 10.2 49 5.22 13 10.8 33.9 4.27
CD21+ (RM) Switched memory B cells (%) 76.2 67.9 70.3 84.6 72.5 94.2 84.7 88.1 90.1 62.9 70.3
CD21- (AM) Switched memory B cells (%) 19.5 32.1 26.6 10.4 26.4 4.79 13.2 8.62 7.86 33 27.7
IgG (mg/dl) 1090 993 723 1420 1132 1132 1165 1159 698 1180 708
IgA (mg/dl) 33 50 22 5 5 356 113 45 91 290 45
IgM (mg/dl) 10 7 55 131 5 284 45 23 24 25 23
IgE (kU/L) 1 1.67 9.94 142 1 2.5 2 3 207 2.47 1
IgG anti-tet NA NA NA R NR R R TR R NA TR
IgG anti-pneumo NA NA NA R NR R R TR R NA TR
TCR α/β NA 96.5% 98.3% 96.5% 89.6% 78.2% 91.6% 96.4% 80.8% 89.6% 96%
TCR γ/δ NA 3.3% 1.5% 3% 8.6% 21.5% 6.4% 1.2% 17.7% 10.2% 3.6%
continued Pt12 Pt13 Pt14 Pt15 Pt16 Pt17 Pt18 Pt19 Pt20 Pt21
Hb (mg/dl) 13.4 13.3 13.8 12.1 15.6 13.8 14.2 16.3 13 12.9
PLT (10x3/ml) 241 169 339 218 232 109 129 173 84 128
WBC (10x3/ml) 3.81 4.82 7.95 7.6 5.15 7.00 5.73 4.99 2 4.61
Eosinophils (% and 10x3/ml) 0.5/20 1.7/80 1.5/120 2.2/170 2/100 1.2/80 1.9/108 2/100 0.7/14 4/0.18
Total lymphocytes (10x3/ml) 0.8 1.6 2.1 2.0 1.8 2290 1.19 1.65 0.51 0.83
CD3+ (% and cell/µl) 75/600 61.3/981 90.6/1902 88.5/1770 85/1530 90.6/2074 87/1035 83.7/1981 96.6/493 70.9/586
CD4+ (% and cell/ µl) 51/408 35.2/563 53.7/1127 57/1140 30/540 54/1236 50.3/599 41.8/690 56.2/287 43.5/361
CD8+ (% and cell/ µl) 17/136 20/320 29.7/623 25.5/510 43/774 32.5/744 32/381 24.4/403 35.2/179 25/207
CD19+ (% and cell/µl) 10.5/84 11.3/176 3.9/82 9.8/196 6.3/113 1.4/32 3.1/178 9.4/155 0.2/1 13.4/111
CD16+56+ (% and cell/µl) 11.6/93 26.2/419 5.1/107 3.7/74 7.5%/135 7.4/169 9.8/561 6.2/102 2.7/14 14.4/119
CD3+CD4+CD27+CD45RO- Naïve T cell (%) 55.9 46.2 24.5 36.9 51.1 68.8 26.5 81 49.4 32.2
CD3+CD4+CD27+CD45RO+ Tcm (%) 38.6 47.5 46 44.3 23.8 24.4 56.7 16.2 37.6 57.3
CD3+CD4+CD27-CD45RO+ Tem (%) 0.088 0.12 0.5 2.64 0.61 0.47 0.97 1.46 1.21 0.37
CD3+CD4+CD27-CD45RO- Temra (%) 3.22 2.72 26.6 12.9 23.4 4.74 13.4 0.55 10.2 8.46
CD3+CD4+CD27+CD45RO+CXCR5+ pTfh (%) 30.2 38.1 19.2 23.4 18.5 15 30.2 15.1 14.7 28
CD27-IgD- Double negative B cells (%) 5.42 5.79 9.72 15.5 3.87 3.85 1.2 3.27 33.3 4.77
CD27+IgD+ Unswitched memory B cells (%) 4.18 4.9 6.63 3.31 3.57 0.41 3.16 2 0 6.57
CD27+IgD- Switched memory B cells (%) 2.26 1.52 12.7 10 0.84 0.36 0.094 0.8 0 0.72
CD27-CD21+ Naïve B cells (%) 82.1 74.7 57.2 62.9 85.2 91.6 69.4 87.9 33.3 31.9
CD27-CD21- TLM B cells (%) 6.32 13.4 15.9 14.4 7.39 5.22 23.1 5.89 33.3 53.7
CD21+ (RM) Switched memory B cells (%) 72 77.9 88.8 74 81.3 73.3 50 66.9 0 79.1
CD21- (AM) Switched memory B cells (%) 21 16.3 8.71 19.4 15.7 13.3 50 21 0 19.4
IgG (mg/dl) 1021 1197 655 618 1052 876 325 726 746 289
IgA (mg/dl) 5 16 550 96 5 <4 <4 91 <4 17
IgM (mg/dl) 8 34 87 189 25 <5 10 87 <5 37
IgE (kU/L) 1 1 3.78 211 92 NA NA NA 2 NA
IgG anti-tet R R NA NA NR NA NA R NA TR
IgG anti-pneumo NR NR NA R NR NA NA R NA R
TCR α/β 97.5% 93.4% 92.5% 97% 87.6% NA 96.9% 83.6% 94.6% 92.3%
TCR γ/δ 3.3% 5.3% 5.9% 2.8% 12.1% NA 2.3% 9.8% 3.4% 2.3%

WBC, White blood cells; PLT, Platelets; HB, Hemoglobin; Tcm, central memory T cells; Tem, effector memory T cells; Temra, terminally differentiated effector memory T cells; pTfh, peripheral follicular helper memory T cells; TLM, tissue like memory B-cells; RM, resting memory B-cells; AM, activated memory B-cells.

NA, Not available; NR, Not Responder; R, Responder; TR, Transient Responder.

Serum immunoglobulin concentrations from Whelan MA et al., J. Clin Immunol 2006 (24); T-cell subsets from Schatorie E.J.H. et al., Clin Immunol 2011 (25); B-cell subsets from Piatosa B. et al., Cytometry part B, Clinical Cytometry 2010 and Duchamp M et al., Immunity, Inflammation and Disease 2014 (26, 27); Regulatory T-cell subsets from van Gent R. et al., Clinical Immunology 2009 (28).